John Cravero, PhD
Contract Attorney at Robert Half Legal
Legal Extern at Law offices of Chicago-Kent, IP Clinic
Affiliate Coordinator, Chicago Affiliate at Pancreatic Cancer Action Network
Legal Extern at University of Illinois at Chicago, Office of Technology Management
Email:jdcravero@me.com
Education:
Ph.D., Molecular Medicine, 2008
Wake Forest University
School of Medicine
Winston-Salem, NC
B.A., Augustana College, Rock Island, IL
Research Interest:
Osteoarthritis, IGF-1 signaling pathways in the chondrocyte, the decrease in the chondrocyte’s response to IGF-1 that occurs with age and OA, and the role of age-related oxidative stress and how it contributes to the decreased IGF-1 response of the chondrocyte.
Postdoctoral Northwest University, August 2009
Publications:
Cravero JD, Carlson CS, Im HJ, Yammani RR, Long D, Loeser RF. Increased expression of the Akt/PKB inhibitor TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth factor 1-mediated cell survival and proteoglycan synthesis. Arthritis Rheum. 2009 Feb;60(2):492-500.
Starkman, B.G., Cravero, J.D., DelCarlo, M. Jr., Loeser, R.F. IGF-1 stimulation of proteoglycan synthesis by chondrocytes requires activation of the PI3-kinase pathway but not ERK MAPK. Biochem. J. (2005) 389: 723-729.
For a listing of additional publications, refer to PubMed, a service provided by the National Library of Medicine.